Luxfer (LXFR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
2024 marked a strong recovery with improved cash generation, margin enhancement, and operational efficiency gains, especially after challenges in 2023.
Strategic review led to the planned sale of the Graphic Arts business, focusing on higher-margin sectors like defense, clean energy, and aerospace.
Net Sales for 2024 were $362.3 million, Adjusted EBITDA $49.8 million (13.7% margin), and free cash flow $47.7 million; net debt reduced to $41.0 million (0.7x leverage).
Over $16 million was returned to shareholders via dividends and share buybacks in 2024.
Voting matters and shareholder proposals
Shareholders will vote on re-election of six directors, approval of remuneration reports, executive compensation, frequency of say-on-pay votes, auditor appointment and remuneration, authority to issue shares, disapplication of preemptive rights, and share repurchase authorization.
Board recommends voting FOR all resolutions and EVERY 1 YEAR for say-on-pay frequency.
Board of directors and corporate governance
Board consists of six directors, five of whom are independent; annual elections with majority voting.
Committees (Audit, Nominating & Governance, Remuneration) are fully independent.
Board diversity: 33% ethnic/gender diverse, average tenure 5 years.
Annual board, committee, and director evaluations; robust succession planning and ongoing board education.
Latest events from Luxfer
- Margin expansion and strong defense/aerospace demand drove robust 2025 results and outlook.LXFR
Investor presentation26 Mar 2026 - Adjusted EBITDA and EPS rose in 2025; 2026 outlook stable with margin focus and optimization.LXFR
Q4 202525 Feb 2026 - Q2 2024 saw margin gains, legal recovery, raised guidance, and Graphic Arts divestiture progress.LXFR
Q2 20242 Feb 2026 - Strong financials, innovation, and clean energy focus drive growth and future opportunities.LXFR
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 delivered higher sales, margin expansion, and raised guidance, with net income rebounding.LXFR
Q3 202417 Jan 2026 - Q4 profit and cash flow surged, with 2025 guidance signaling stable, margin-focused growth.LXFR
Q4 202423 Dec 2025 - Strong recovery, portfolio focus, and ESG progress drive 2025 shareholder meeting agenda.LXFR
Proxy Filing2 Dec 2025 - AGM to vote on directors, compensation, auditor, and share issuance authorities.LXFR
Proxy Filing2 Dec 2025 - Q1 2025 sales up 8.5%–9%, adjusted EPS up 15%, net income nearly doubled, guidance reaffirmed.LXFR
Q1 202529 Nov 2025